Lenz Therapeutics rallies $47m Series A

Lenz Therapeutics, a biopharmaceutical company, has raised $47 million in Series A financing.

Lenz Therapeutics, a biopharmaceutical company, has raised $47 million in Series A financing. The investors were Versant Ventures and RA Capital Management.

Source: Press Release